These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31999902)

  • 21. Measuring health-related quality of life in chronic obstructive pulmonary disease: properties of the EQ-5D-5L and PROMIS-43 short form.
    Lin FJ; Pickard AS; Krishnan JA; Joo MJ; Au DH; Carson SS; Gillespie S; Henderson AG; Lindenauer PK; McBurnie MA; Mularski RA; Naureckas ET; Vollmer WM; Lee TA;
    BMC Med Res Methodol; 2014 Jun; 14():78. PubMed ID: 24934150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.
    Lenferink A; Brusse-Keizer M; van der Valk PD; Frith PA; Zwerink M; Monninkhof EM; van der Palen J; Effing TW
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011682. PubMed ID: 28777450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
    Kew KM; Mavergames C; Walters JA
    Cochrane Database Syst Rev; 2013 Oct; (10):CD010177. PubMed ID: 24127118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of allergic phenotype on respiratory symptoms and exacerbations in patients with chronic obstructive pulmonary disease.
    Jamieson DB; Matsui EC; Belli A; McCormack MC; Peng E; Pierre-Louis S; Curtin-Brosnan J; Breysse PN; Diette GB; Hansel NN
    Am J Respir Crit Care Med; 2013 Jul; 188(2):187-92. PubMed ID: 23668455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.
    Chong J; Leung B; Poole P
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD002309. PubMed ID: 28922692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease.
    Solem CT; Sun SX; Sudharshan L; Macahilig C; Katyal M; Gao X
    Int J Chron Obstruct Pulmon Dis; 2013; 8():641-52. PubMed ID: 24376348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease.
    Howcroft M; Walters EH; Wood-Baker R; Walters JA
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD005074. PubMed ID: 27990628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Relationship Between Cough Reflex Sensitivity and Exacerbation Frequency in Chronic Obstructive Pulmonary Disease.
    Cho PSP; Fletcher HV; Turner RD; Patel IS; Jolley CJ; Birring SS
    Lung; 2020 Aug; 198(4):617-628. PubMed ID: 32561993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of current cough on health-related quality of life in patients with COPD.
    Deslee G; Burgel PR; Escamilla R; Chanez P; Court-Fortune I; Nesme-Meyer P; Brinchault-Rabin G; Perez T; Jebrak G; Caillaud D; Paillasseur JL; Roche N
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2091-2097. PubMed ID: 27695305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of symptom burden and adherence to respiratory medications in individuals self-reporting a diagnosis of COPD within a community pharmacy setting.
    Bollmeier SG; Seaton TL; Prosser TR; Chou YT; Reckenberg K; Hahn B; Stanford RH; Ray R
    J Am Pharm Assoc (2003); 2019; 59(4):479-488.e1. PubMed ID: 31126830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of frailty in primary care patients with COPD: the Greek UNLOCK study.
    Ierodiakonou D; Kampouraki M; Poulonirakis I; Papadokostakis P; Lintovoi E; Karanassos D; Maltezis K; Chorti M; Petrovitsos E; Dimopoulou S; Hamind S; Gialamas I; Athanasiou P; Bempi V; Lambraki I; Tsiligianni I
    BMC Pulm Med; 2019 Mar; 19(1):63. PubMed ID: 30876423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient reported outcome measures in chronic obstructive pulmonary disease: Which to use?
    Ekström M; Sundh J; Larsson K
    Expert Rev Respir Med; 2016; 10(3):351-62. PubMed ID: 26808786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contemporary issues in the care of patients with chronic obstructive pulmonary disease.
    Urbano FL; Pascual RM
    J Manag Care Pharm; 2005 Jun; 11(5 Suppl A):S2-13; quiz S14-6. PubMed ID: 15934804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subjects with COPD and productive cough have an increased risk for exacerbations and death.
    Lindberg A; Sawalha S; Hedman L; Larsson LG; Lundbäck B; Rönmark E
    Respir Med; 2015 Jan; 109(1):88-95. PubMed ID: 25528948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Once-daily long-acting beta₂-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease.
    Sliwka A; Jankowski M; Gross-Sondej I; Storman M; Nowobilski R; Bala MM
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012355. PubMed ID: 30141826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of a New Risk Measure for Chronic Obstructive Pulmonary Disease Exacerbation Using Health Insurance Claims Data.
    Stanford RH; Nag A; Mapel DW; Lee TA; Rosiello R; Vekeman F; Gauthier-Loiselle M; Duh MS; Merrigan JF; Schatz M
    Ann Am Thorac Soc; 2016 Jul; 13(7):1067-75. PubMed ID: 27070274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD).
    Horita N; Goto A; Shibata Y; Ota E; Nakashima K; Nagai K; Kaneko T
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD012066. PubMed ID: 28185242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials.
    McGarvey L; Morice AH; Smith JA; Birring SS; Chuecos F; Seoane B; Jarreta D
    BMJ Open Respir Res; 2016; 3(1):e000148. PubMed ID: 28074135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Critical role of smoking and household dampness during childhood for adult phlegm and cough: a research example from a prospective cohort study in Great Britain.
    Cable N; Kelly Y; Bartley M; Sato Y; Sacker A
    BMJ Open; 2014 Apr; 4(4):e004807. PubMed ID: 24747796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.